About
PE-backed roll-up of leading retina practices across the US. Sold an 85% stake to distributor Cencora (2025) for $4.6bn — the sector's largest 2025 exit.
HQ: US
Funding
Acquired by Cencora ($4.6bn, 2025)
—Company profile
The largest retina-only physician practice group — sold to Cencora for $4.6bn.
PE-backed roll-up of leading retina practices across the US. Sold an 85% stake to distributor Cencora (2025) for $4.6bn — the sector's largest 2025 exit.
HQ: US